Brief: Interpace Biosciences Q2 Revenue USD 9.232 Million
07/08/2025 21:05
Aug 07 (Reuters) - Interpace Biosciences Q2 operating income USD -468 thousand. Q2 gross profit USD 5.276 million Q2 net income USD -640 thousand Q2 operating expenses USD 5.744 million
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million